1,116 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Acquired by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. acquired a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 1,116 shares of the biotechnology company's stock, valued at approximately $587,000.

A number of other institutional investors have also recently added to or reduced their stakes in AXON. Brighton Jones LLC acquired a new position in Axon Enterprise during the 4th quarter worth $480,000. Kingsview Wealth Management LLC purchased a new stake in Axon Enterprise in the 4th quarter valued at approximately $212,000. Empowered Funds LLC lifted its stake in Axon Enterprise by 89.2% in the 4th quarter. Empowered Funds LLC now owns 1,871 shares of the biotechnology company's stock valued at $1,112,000 after buying an additional 882 shares in the last quarter. Savant Capital LLC raised its position in shares of Axon Enterprise by 5.7% in the 4th quarter. Savant Capital LLC now owns 1,080 shares of the biotechnology company's stock worth $642,000 after buying an additional 58 shares during the period. Finally, Stonebridge Financial Group LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth $53,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Wall Street Analysts Forecast Growth

AXON has been the subject of several recent analyst reports. Needham & Company LLC raised their target price on Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a research note on Thursday, May 8th. Bank of America raised their price objective on shares of Axon Enterprise from $750.00 to $895.00 and gave the company a "buy" rating in a research note on Wednesday, June 4th. Craig Hallum cut Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Barclays lifted their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Finally, The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $699.55.

Axon Enterprise Stock Up 0.7%

Shares of AXON traded up $5.43 during trading hours on Friday, reaching $780.63. 358,906 shares of the stock traded hands, compared to its average volume of 719,761. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a fifty day simple moving average of $669.47 and a 200 day simple moving average of $621.62. Axon Enterprise, Inc. has a 52 week low of $279.02 and a 52 week high of $806.64. The company has a market cap of $60.77 billion, a price-to-earnings ratio of 201.71, a PEG ratio of 5.17 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The biotechnology company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.34 by $0.07. The company had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. Axon Enterprise's revenue for the quarter was up 31.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.15 earnings per share. On average, equities analysts forecast that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Insider Buying and Selling

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This represents a 15.87% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Michael Garnreiter sold 5,913 shares of the stock in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the completion of the sale, the director now directly owns 17,740 shares of the company's stock, valued at $13,482,400. This represents a 25.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,969 shares of company stock worth $29,909,594 in the last quarter. Corporate insiders own 4.40% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.